Genetic Susceptibility to Cancer

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
Who is this for?
Show terms as
1FDA treatments7Active trials11Specialists8Treatment centers

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic Susceptibility to Cancer is treated with 1 medication in our database, including MLK Kit F2. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Genetic Susceptibility to Cancer treatment below.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

NORD ↗

FDA & Trial Timeline

10 events
Oct 2026Genetic Investigation of Cancer Predisposition

The University of Texas Health Science Center at San Antonio

TrialNOT YET RECRUITING
Jun 2026Outcomes of Health Care Transition for AYA With a Cancer Predisposition

St. Jude Children's Research Hospital

TrialNOT YET RECRUITING
May 2026Bundled Cancer Screening and Genetic Services Navigation

Georgetown University — NA

TrialNOT YET RECRUITING
Feb 2026Germline Testing for Predisposition to Myeloid Malignancies

Christopher Reilly — NA

TrialNOT YET RECRUITING
Dec 2025Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon

Duke University — PHASE1

TrialNOT YET RECRUITING
Jul 2025Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

TrialRECRUITING
Jul 2025MEASUREMENT OF CIRCULATING MUTATION BURDEN

Centre Francois Baclesse

TrialRECRUITING
Jun 2025Implementing Polygenic Risk Scores for Breast Cancer Prevention: a Feasibility Study

Boccia Stefania — NA

TrialNOT YET RECRUITING
Jun 2025The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).

Institute of Cancer Research, United Kingdom

TrialRECRUITING
Jun 2025Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study

Catholic University of the Sacred Heart

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

MLK Kit F2

marcaine, lidocaine, kenalog, povidone iodine· Unknown

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program fo

View Details →Copay Card ↗Patient Assistance ↗

Clinical Trials

7 recruitingView all trials with filters →
N/A2 trials
EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer
N/A
Actively Recruiting
· Sites: Besançon; Dijon +4 more · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
N/A
Active
PI: Angela R Bradbury, MD (University of Pennsylvania) · Sites: Philadelphia, Pennsylvania · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Other5 trials
ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies
Actively Recruiting
· Sites: Shanghai, Shanghai Municipality
View on ClinicalTrials.gov ↗I'm interested →
Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
Actively Recruiting
· Sites: Newcastle, New South Wales; Sydney, New South Wales +1 more · Age: 0–21 yrs
View on ClinicalTrials.gov ↗I'm interested →
Rare Tumors and Cancer Predisposition in Individuals and Families
Actively Recruiting
PI: Sharon A Savage, M.D. (National Cancer Institute (NCI)) · Sites: Bethesda, Maryland; Rockville, Maryland
View on ClinicalTrials.gov ↗I'm interested →
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
Active
PI: Sharon A Savage, M.D. (National Cancer Institute (NCI)) · Sites: Bethesda, Maryland
View on ClinicalTrials.gov ↗I'm interested →
Investigating the Role of Genetics in Disease Predisposition
Enrolling by Invitation
PI: Raheleh Rahbari (Wellcome Sanger Institute) · Sites: Cambridge
View on ClinicalTrials.gov ↗I'm interested →

Specialists

11 foundView all specialists →
WM
W. Marston Linehan, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 6 active trials
SM
Sharon A Savage, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 7 active trials
KM
Kim E. Nichols, MD
Memphis, Tennessee
Specialist

Rare Disease Specialist

PI on 2 active trials
PP
Patricia L Dahia, MD, PhD
Specialist
PI on 2 active trials
AP
Anne-Paule Gimenez-Roqueplo, MD, PhD
Specialist
PI on 2 active trials
PJ
Patrick Lynch, MD, JD
Specialist
PI on 2 active trials
AB
Angela R Bradbury
PHILADELPHIA, PA
Specialist
PI on 1 active trial
RR
Raheleh Rahbari
Specialist
PI on 1 active trial
FV
Florent de Vathaire
Specialist
PI on 1 active trial
ES
Evis Sala
NEW YORK, NY
Specialist
PI on 1 active trial
FP
François GHIRINGHELLI, PU-PH
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Genetic Susceptibility to Cancer.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Genetic Susceptibility to CancerForum →

No community posts yet. Be the first to share your experience with Genetic Susceptibility to Cancer.

Start the conversation →

Latest news about Genetic Susceptibility to Cancer

3 articles
ResearchPUBMEDApr 1, 2026
Early Satiety in Individuals With Cancer: A Scoping Review of an Orphan Symptom.
Researchers reviewed 78 studies about early satiety (feeling full quickly after eating small amounts) in cancer patients. They found this symptom is common but …
ResearchPUBMEDMar 26, 2026
[New ways in interdisciplinarity: internal medicine meets human genetics : When frequent conditions become rare and rare conditions become frequent].
Doctors are learning that common diseases are actually made up of many different rare subtypes when scientists look at their genetic makeup. By understanding th…
Clinical trialCLINICALTRIALSMar 26, 2026
Trial Completed: Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate (NCT01046487)
Researchers completed a study testing two cancer drugs given together: imatinib mesylate and cyclophosphamide. The study involved 26 patients and aimed to find …
See all news about Genetic Susceptibility to Cancer →

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Genetic Susceptibility to Cancer

What is Genetic Susceptibility to Cancer?

Genetic Susceptibility to Cancer is treated with 1 medication in our database, including MLK Kit F2. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Genetic Susceptibility to Cancer treatment below.

Are there clinical trials for Genetic Susceptibility to Cancer?

Yes — 7 recruiting clinical trials are currently listed for Genetic Susceptibility to Cancer on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Genetic Susceptibility to Cancer?

11 specialists and care centers treating Genetic Susceptibility to Cancer are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Genetic Susceptibility to Cancer?

1 FDA-approved treatment are currently tracked on UniteRare for Genetic Susceptibility to Cancer. See the treatments and support programs sections for copay assistance, eligibility, and contact details.